Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (101-110 of 273) with videos related to

Pageof 28
Sort By:
Molecular Therapy. Methods & Clinical Development|October 9, 2024
DNA contamination within recombinant adeno-associated virus preparations correlates with decreased CD34<sup>+</sup> cell clonogenic potentialChristopher R Luthers, Sung-Min Ha, Annika Mittelhauser, et al.
Clinical Immunology (Orlando, Fla.)|August 23, 2005
Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)Belinda Chan, Diane Wara, John Bastian, et al.
Blood|November 18, 2005
Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimenNoboru Mitsuhashi, Jacqueline Fischer-Lougheed, Irina Shulkin, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiencyDonald B Kohn, Michael S Hershfield, Jennifer M Puck, et al.
Experimental Hematology|September 20, 2006
Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposonRoger P Hollis, Sarah J Nightingale, Xiuli Wang, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Hematopoietic stem cell gene therapy for the treatment of X-linked agammaglobulinemiaChristopher R Luthers, Annika Mittelhauser, Aurelien Colamartino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2020
AT1R Activating Autoantibodies in Hematopoietic Stem Cell TransplantationKathryn L Bradford, Meghan Pearl, Donald B Kohn, et al.
Journal of Virology|August 14, 2003
The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cellsDennis L Haas, Carolyn Lutzko, Aaron C Logan, et al.
Human Gene Therapy|July 21, 2022
Improving Lentiviral Transduction of Human Adipose-Derived Mesenchymal Stem CellsKevin Collon, Matthew C Gallo, Jennifer A Bell, et al.
Blood|March 30, 2017
Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patientsAaron R Cooper, Georgia R Lill, Kit Shaw, et al.
Pageof 28

Showing results (101-110 of 273) with videos related to

Sort By:
Pageof 28
Molecular Therapy. Methods & Clinical Development|October 9, 2024
DNA contamination within recombinant adeno-associated virus preparations correlates with decreased CD34<sup>+</sup> cell clonogenic potentialChristopher R Luthers, Sung-Min Ha, Annika Mittelhauser, et al.
Clinical Immunology (Orlando, Fla.)|August 23, 2005
Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)Belinda Chan, Diane Wara, John Bastian, et al.
Blood|November 18, 2005
Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimenNoboru Mitsuhashi, Jacqueline Fischer-Lougheed, Irina Shulkin, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiencyDonald B Kohn, Michael S Hershfield, Jennifer M Puck, et al.
Experimental Hematology|September 20, 2006
Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposonRoger P Hollis, Sarah J Nightingale, Xiuli Wang, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Hematopoietic stem cell gene therapy for the treatment of X-linked agammaglobulinemiaChristopher R Luthers, Annika Mittelhauser, Aurelien Colamartino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2020
AT1R Activating Autoantibodies in Hematopoietic Stem Cell TransplantationKathryn L Bradford, Meghan Pearl, Donald B Kohn, et al.
Journal of Virology|August 14, 2003
The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cellsDennis L Haas, Carolyn Lutzko, Aaron C Logan, et al.
Human Gene Therapy|July 21, 2022
Improving Lentiviral Transduction of Human Adipose-Derived Mesenchymal Stem CellsKevin Collon, Matthew C Gallo, Jennifer A Bell, et al.
Blood|March 30, 2017
Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patientsAaron R Cooper, Georgia R Lill, Kit Shaw, et al.
Pageof 28